01/17/2025
Spravato®: A New Hope for Treatment-Resistant Depression
For those with depression that hasn’t improved with traditional treatments, Spravato® (esketamine nasal spray) offers a breakthrough. Here’s why it’s gaining attention:
🌟 Why Spravato®?
Unique Mechanism: Unlike typical antidepressants that focus on serotonin, Spravato® targets glutamate pathways, which are key in mood regulation and brain plasticity.
Rapid Relief: Traditional antidepressants can take weeks to work. Spravato® often shows improvement within hours — a critical benefit for those in need of fast relief.
Clinically Proven: Studies show that when combined with an oral antidepressant, Spravato® has helped many people with treatment-resistant depression find renewed hope.
Spravato® is administered in a controlled clinical setting, ensuring safety while patients experience this transformative therapy.
At Madison KetaHealth NYC, we’re committed to providing innovative care options like Spravato® to help our patients overcome depression. Let’s take the first step together.
📍 425 Madison Ave, Fl 14, New York, NY, 10017
📞 (212) 644-9100
🌐 madisonketahealth.nyc
